Publication date: Jul 19, 2024
Whilst the benefits of telehealth were identified during the COVID-19 pandemic, we noted barriers to its use at a vital time. Through a health service improvement approach, we sought to increase allied health professional capability in telehealth, but we also sought to understand if there were risks associated with its use. We designed and implemented tools to evaluate allied health professional competence and confidence in using telehealth with private and public patients in a metropolitan teaching hospital setting. With an emphasis on technology capability, we undertook audits over three consecutive years (2020 to 2022) of allied health professional telehealth occasions of service reporting on compliance with the audit criteria and investigating staff confidence in undertaking telehealth sessions using a co-designed survey. The audit tool and confidence survey results were used to identify risk factors to telehealth service delivery using a Modified Health Failure Modes, Effects Analysis. Although confidence levels were relatively high among staff, confidence in managing safety factors and technology risks associated with telehealth were not initially verified by the audit findings. Remedial efforts resulted in service improvements in many identified risk factors, yet technology performance and its troubleshooting remained a primary variable in the ability of staff to comply with the requirements of the real-time audits. Health workers using telehealth should have training to engage safely and effectively in telehealth care and the technology.
Open Access PDF
Concepts | Keywords |
---|---|
Basel | allied health |
Pandemic | allied health professional |
Professional | co-design |
Telehealth | competence |
confidence | |
technology | |
telehealth |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | VO | time |
drug | DRUGBANK | Etoperidone |
disease | IDO | quality |
drug | DRUGBANK | Coenzyme M |
disease | VO | population |
disease | VO | efficiency |
disease | VO | document |
disease | VO | effective |
drug | DRUGBANK | Serine |
drug | DRUGBANK | Creatinolfosfate |
disease | VO | Equity |
disease | IDO | process |
drug | DRUGBANK | Methylergometrine |
drug | DRUGBANK | Ilex paraguariensis leaf |
drug | DRUGBANK | Pentaerythritol tetranitrate |
disease | VO | efficient |
disease | MESH | Causes |
disease | IDO | intervention |
drug | DRUGBANK | Trestolone |
disease | VO | Gap |
disease | VO | monthly |
drug | DRUGBANK | Fenamole |
drug | DRUGBANK | Methionine |